Texas Telehealth Pharmacy Rule Signals a New Compliance Era: What Every Pharmacy Should Know About the Board’s Proposed Informed Consent Requirements - Buchanan Ingersoll & Rooney PC
Texas proposes new informed consent requirements for telehealth pharmacy services, impacting pharmacies dispensing controlled substances via telemedicine.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 16, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies in Texas or serving Texas patients via telehealth should confirm how it applies to their specific situation before acting. There is a time constraint attached: Comment period likely 30-60 days from publication; monitor Texas Register for exact date.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Texas Board of Pharmacy proposed rule requiring pharmacies to obtain and document patient informed consent before dispensing controlled substances via telehealth, including specific disclosures about risks, alternatives, and prescribing practitioner details.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies in Texas or serving Texas patients via telehealth
What you must do
Review and update telehealth consent processes to comply with proposed Texas requirements; submit comments on proposed rule before deadline.
Deadline
Comment period likely 30-60 days from publication; monitor Texas Register for exact date.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- IL HB0004: MEDICAID-PHARMACY SERVICES
- Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Extension of Effective Date of Final Resolution of Drug Efficacy Study Implementation 7661
- Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
- Psychedelic Drugs: Considerations for Clinical Investigations; Guidance for Industry; Availability
- Amanda Ward, N.D.; Decision and Order